Alex Kavros

Alex Kavros, PhD, serves as the Executive Vice President of Global Scientific & Regulatory Affairs at Avance Clinical since February 2024. Previously, Alex held the position of Vice President for Business Optimisation & Innovation at PrimeVigilance Ltd., where responsibilities included leading strategic initiatives, supporting client engagements, and enhancing regulatory and drug development consultancy projects. Alex's extensive experience in regulatory affairs includes roles at Vifor Pharma, Worldwide Clinical Trials, and BIOTRONIK, focusing on clinical regulatory strategy, submission management, and cross-functional collaboration. Alex obtained a PhD in Organic/Polymer Chemistry from Lancaster University, further supported by a Bachelor's degree in Chemistry and Polymer Science from the same institution.